Annual Net Income
-$234.63 M
-$51.51 M-28.13%
31 December 2023
Summary:
Lyell Immunopharma annual net profit is currently -$234.63 million, with the most recent change of -$51.51 million (-28.13%) on 31 December 2023. During the last 3 years, it has fallen by -$30.16 million (-14.75%). LYEL annual net income is now -81.36% below its all-time high of -$129.38 million, reached on 31 December 2019.LYEL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$44.58 M
+$1.23 M+2.68%
30 September 2024
Summary:
Lyell Immunopharma quarterly net profit is currently -$44.58 million, with the most recent change of +$1.23 million (+2.68%) on 30 September 2024. Over the past year, it has increased by +$6.27 million (+12.33%). LYEL quarterly net income is now -430.94% below its all-time high of -$8.40 million, reached on 31 December 2022.LYEL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$203.99 M
+$6.27 M+2.98%
30 September 2024
Summary:
Lyell Immunopharma TTM net profit is currently -$203.99 million, with the most recent change of +$6.27 million (+2.98%) on 30 September 2024. Over the past year, it has dropped by -$13.89 million (-7.31%). LYEL TTM net income is now -597.64% below its all-time high of -$29.24 million, reached on 31 March 2020.LYEL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.1% | +12.3% | -7.3% |
| 3 y3 years | -14.8% | +8.8% | +0.7% |
| 5 y5 years | - | - | - |
LYEL Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.1% | +6.2% | -430.9% | +46.7% | -12.1% | +22.5% |
| 5 y | 5 years | -81.4% | +6.2% | -430.9% | +55.7% | -597.6% | +22.5% |
| alltime | all time | -81.4% | +6.2% | -430.9% | +55.7% | -597.6% | +22.5% |
Lyell Immunopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$44.58 M(-2.7%) | -$203.99 M(-3.0%) |
| June 2024 | - | -$45.81 M(-24.5%) | -$210.26 M(-7.9%) |
| Mar 2024 | - | -$60.67 M(+14.6%) | -$228.34 M(-2.7%) |
| Dec 2023 | -$234.63 M(+28.1%) | -$52.93 M(+4.1%) | -$234.63 M(+23.4%) |
| Sept 2023 | - | -$50.85 M(-20.4%) | -$190.10 M(-9.3%) |
| June 2023 | - | -$63.89 M(-4.6%) | -$209.50 M(+15.2%) |
| Mar 2023 | - | -$66.96 M(+697.4%) | -$181.93 M(-0.6%) |
| Dec 2022 | -$183.12 M | -$8.40 M(-88.0%) | -$183.12 M(-29.1%) |
| Sept 2022 | - | -$70.25 M(+93.4%) | -$258.43 M(+9.0%) |
| June 2022 | - | -$36.32 M(-46.7%) | -$237.05 M(-10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$68.14 M(-18.6%) | -$263.32 M(+5.2%) |
| Dec 2021 | -$250.22 M(+22.4%) | -$83.71 M(+71.3%) | -$250.22 M(+21.8%) |
| Sept 2021 | - | -$48.88 M(-21.9%) | -$205.37 M(+6.8%) |
| June 2021 | - | -$62.59 M(+13.7%) | -$192.21 M(-16.5%) |
| Mar 2021 | - | -$55.04 M(+41.7%) | -$230.28 M(+12.6%) |
| Dec 2020 | -$204.47 M(+58.0%) | - | - |
| Dec 2020 | - | -$38.86 M(+8.8%) | -$204.47 M(+23.5%) |
| Sept 2020 | - | -$35.72 M(-64.5%) | -$165.62 M(+27.5%) |
| June 2020 | - | -$100.66 M(+244.2%) | -$129.90 M(+344.2%) |
| Mar 2020 | - | -$29.24 M | -$29.24 M |
| Dec 2019 | -$129.38 M | - | - |
FAQ
- What is Lyell Immunopharma annual net profit?
- What is the all time high annual net income for Lyell Immunopharma?
- What is Lyell Immunopharma annual net income year-on-year change?
- What is Lyell Immunopharma quarterly net profit?
- What is the all time high quarterly net income for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly net income year-on-year change?
- What is Lyell Immunopharma TTM net profit?
- What is the all time high TTM net income for Lyell Immunopharma?
- What is Lyell Immunopharma TTM net income year-on-year change?
What is Lyell Immunopharma annual net profit?
The current annual net income of LYEL is -$234.63 M
What is the all time high annual net income for Lyell Immunopharma?
Lyell Immunopharma all-time high annual net profit is -$129.38 M
What is Lyell Immunopharma annual net income year-on-year change?
Over the past year, LYEL annual net profit has changed by -$51.51 M (-28.13%)
What is Lyell Immunopharma quarterly net profit?
The current quarterly net income of LYEL is -$44.58 M
What is the all time high quarterly net income for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly net profit is -$8.40 M
What is Lyell Immunopharma quarterly net income year-on-year change?
Over the past year, LYEL quarterly net profit has changed by +$6.27 M (+12.33%)
What is Lyell Immunopharma TTM net profit?
The current TTM net income of LYEL is -$203.99 M
What is the all time high TTM net income for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM net profit is -$29.24 M
What is Lyell Immunopharma TTM net income year-on-year change?
Over the past year, LYEL TTM net profit has changed by -$13.89 M (-7.31%)